BACKGROUND: Asbestos is a well-established occupational carcinogen, with strong evidence linking its exposure to lung cancer. Despite increasing awareness of its health risks, asbestos continues to be used in many countries. We aimed to evaluate the global burden of lung cancer attributable to occupational asbestos exposure and to analyze its epidemiological patterns across time and by regions, sex, and age. METHODS: We utilized lung cancer data from the Global Burden of Disease (GBD) 2021 database, including information on new cases, deaths, and disability-adjusted life-years (DALYs), along with their age-standardized rates by gender and age groups. Temporal trends were examined using Joinpoint regression models with 95% confidence intervals (CIs). The timeline data on global asbestos bans were retrieved from the International Ban Asbestos Secretariat. RESULTS: We observed, approximately 25 years after the complete ban on asbestos use, a declining trend for lung cancer incidence, as well as for mortality and DALYs due to asbestos exposure. In 2021, occupational asbestos exposure accounted for 9.4% of global lung cancer deaths and 7.2% of DALYs. Between 1990 and 2021, the number of asbestos-related lung cancer deaths increased from 0.13 million to 0.19 million, while DALYs rose from 2.58 million to 3.34 million. The highest deaths and DALYs were observed in regions with high Socio-demographic Index (SDI), though the most rapid increases occurred in lower SDI regions. Over time, lung cancer burden shifted towards older populations, especially those aged over 70. CONCLUSIONS: We found, for the first time, that a complete ban on asbestos with a lag time of 25 years could effectively reduce lung cancer incidence along with asbestos-related deaths and DALYs. These findings underscore the urgent need for a complete ban on asbestos (especially chrysotile).

Biomedical Center Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Cancer Prevention Zhejiang Cancer Hospital Hangzhou 310022 China

Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany

Hangzhou Institute of Medicine Chinese Academy of Sciences Hangzhou 310018 China

Postgraduate training base Alliance of Wenzhou Medical University Wenzhou 325000 China

School of Public Health Hangzhou Medical College Hangzhou 311300 China

School of Public Health Hangzhou Normal University Hangzhou 311121 China

Zobrazit více v PubMed

De Groot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer. Transl Lung Cancer Res. 2018;7(3):220–33. PubMed DOI PMC

SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute; 2024. Available from: https://seer.cancer.gov/statistics-network/explorer/. Updated: 2024 Jun 27; cited 2024 Aug 5.

Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA A Cancer J Clinicians. 2024;74(1):12–49. PubMed

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. PubMed

Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–61. PubMed PMC

International Agency for Research on Cancer. Agents Classified by Cancer Sites with Sufficient or Limited Evidence in Humans. Lyon, France; 2025. Available from: https://monographs.iarc.who.int/wpcontent/uploads/2019/07/Classifications_by_cancer_site.pdf. Cited 2025 Jul 6.

Olsson AC, Vermeulen R, Schüz J, Kromhout H, Pesch B, Peters S, et al. Exposure-Response Analyses of Asbestos and Lung Cancer Subtypes in a Pooled Analysis of Case-Control Studies. Epidemiology. 2017;28(2):288–99. PubMed DOI PMC

Olsson A, Bouaoun L, Schüz J, Vermeulen R, Behrens T, Ge C, et al. Lung cancer risks associated with occupational exposure to pairs of five lung carcinogens: results from a pooled analysis of case-control studies (SYNERGY). Environ Health Perspect. 2024;132(1):017005-1–10. PubMed DOI PMC

Klebe S, Leigh J, Henderson DW, Nurminen M. Asbestos, Smoking and Lung Cancer: An Update. IJERPH. 2019;17(1):258. PubMed DOI PMC

Ge C, Peters S, Olsson A, Portengen L, Schüz J, Almansa J, et al. Respirable crystalline silica exposure, smoking, and lung cancer subtype risks. A pooled analysis of case-control studies. Am J Respir Crit Care Med. 2020;202(3):412–21. PubMed DOI PMC

Kogel JE. Society for mining, metallurgy, and exploration, editors. Industrial minerals & rocks: commodities, markets, and uses. 7. ed. Littleton, Colo: Society for Mining, Metallurgy, and Exploration; 2006. p. 1548.

Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens—Part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10(5):453–4. PubMed DOI

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Arsenic, metals, fibres, and dusts. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11–465. PubMed PMC

Merewether ERA. The Occurrence of Pulmonary Fibrosis and other Pulmonary Affections in Asbestos Workers. J Ind Hyg. 1930;12:198–222.

Lynch KM, Smith WA. Pulmonary Asbestosis III: Carcinoma of Lung in Asbesto-Silicosis. The American Journal of Cancer. 1935;24(1):56–64. DOI

Roodhouse Gloyne S. Two cases of squamous carcinoma of the lung occurring in asbestosis. Tubercle. 1935;17(1):5-IN2. DOI

Hueper WC. Occupational tumors and allied diseases. Springfield, Illinois: Charles C Thomas Publisher; 1942.

Doll R. Mortality from Lung Cancer in Asbestos Workers. Occup Environ Med. 1955;12(2):81–6. PubMed DOI PMC

McCormack V, Peto J, Byrnes G, Straif K, Boffetta P. Estimating the asbestos-related lung cancer burden from mesothelioma mortality. Br J Cancer. 2012;106(3):575–84. PubMed DOI PMC

Chen T, Sun XM, Wu L. High Time for Complete Ban on Asbestos Use in Developing Countries. JAMA Oncol. 2019;5(6):779. PubMed DOI

Lin RT, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. The Lancet. 2007;369(9564):844–9. PubMed DOI

Carbone M, Adusumilli PS, Alexander HR, Baas P, Bardelli F, Bononi A, et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69(5):402–29. PubMed PMC

The United States Geological Survey. Mineral commodity summaries 2025. US Geological Survey; 2025. Available from: https://pubs.usgs.gov/publication/mcs2025. Cited 2025 Jul 10.

Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2021 (GBD 2021) Results. https://vizhub.healthdata.org/gbd-results/.

Safiri S, Sepanlou SG, Ikuta KS, Bisignano C, Salimzadeh H, Delavari A, et al. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology. 2019;4(12):913–33. PubMed DOI PMC

Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1223–49. PubMed DOI PMC

Kazan-Allen L. Current Asbestos Bans. International Ban Asbestos Secretariat; 2024. Available from: http://www.ibasecretariat.org/alpha_ban_list.php. PubMed

Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun. 2021;41(10):1037–48. PubMed DOI PMC

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statist Med. 2000;19(3):335–51. PubMed DOI

Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, et al. Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 2000;11(1):31–5. PubMed

Wong JYY, Rice C, Blair A, Silverman DT. Mesothelioma risk among those exposed to chrysotile asbestos only and mixtures that include amphibole: a case–control study in the USA, 1975–1980. Occup Environ Med. 2021;78(3):199–202. PubMed DOI PMC

Bernstein DM. The health effects of short fiber chrysotile and amphibole asbestos. Crit Rev Toxicol. 2022;52(2):89–112. PubMed DOI

Hodgson J. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44(8):565–601. PubMed DOI

Merler E, Somigliana A, Girardi P, Barbieri PG. Residual fibre lung burden among patients with pleural mesothelioma who have been occupationally exposed to asbestos. Occup Environ Med. 2017;74(3):218–27. PubMed DOI

Analysis of tissue mineral fiber content. InPathology of asbestos-associated diseases. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. pp. 253–92.

Thomsen RW, Riis AH, Flachs EM, Garabrant DH, Bonde JPE, Sørensen HT. Risk of asbestosis, mesothelioma, other lung disease or death among motor vehicle mechanics: a 45-year Danish cohort study. Thorax. 2022;77(5):477–85. PubMed DOI

Kuang Z, Wang J, Liu K, Wu J, Ge Y, Zhu G, et al. Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021. eClinicalMedicine. 2024;75:102804. PubMed DOI PMC

Pinheiro GA, Antao VCS, Bang KM, Attfield MD. Malignant Mesothelioma Surveillance: A Comparison of ICD 10 Mortality Data with SEER Incidence Data in Nine Areas of the United States. Int J Occup Environ Health. 2004;10(3):251–5. PubMed DOI

McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med. 2005;55(2):79–87. PubMed DOI

Hendrickx M. Naturally occurring asbestos in eastern Australia: a review of geological occurrence, disturbance and mesothelioma risk. Environ Geol. 2009;57(4):909–26. DOI

Frank AL, Van Zandwijk N. Asbestos history and use. Lung Cancer. 2024;193: 107828. PubMed DOI

Wagner JC, Sleggs CA, Marchand P. Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province. Occup Environ Med. 1960;17(4):260–71. PubMed DOI PMC

Hansen J, de Klerk NH, Musk AW, Hobbs MS. Environmental exposure to crocidolite and mesothelioma: exposure-response relationships. Am J Respir Crit Care Med. 1998;157(1):69–75. PubMed DOI

Zhai Z, Ruan J, Zheng Y, Xiang D, Li N, Hu J, et al. Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017. JAMA Netw Open. 2021;4(8): e2120360. PubMed DOI PMC

Järvholm B, Englund A, Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med. 1999;56(2):110–3. PubMed DOI PMC

Hemminki K, Försti A, Chen T, Hemminki A. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden. BMC Cancer. 2021;21(1):1189. PubMed DOI PMC

Centers for Disease Control and Prevention (CDC). Malignant mesothelioma mortality–United States, 1999–2005. MMWR Morb Mortal Wkly Rep. 2009;58(15):393–6. PubMed

Han Y, Zhang T, Chen H, Yang X. Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: Results from the Global Burden of Disease Study 2019. Crit Rev Oncol Hematol. 2022;179: 103821. PubMed DOI

Huang Q, Chen Y, Lian L, Lei Q, Chen J, Wu L, et al. Burden of malignant mesothelioma in China during 1990–2019 and the projections through 2029. Journal of the National Cancer Center. 2024;4(3):214–22. PubMed DOI PMC

Fan Y, Jiang Y, Li X, Li X, Li Y, Wu H, et al. Burden of Lung Cancer Attributable to Occupational Carcinogens from 1990 to 2019 and Projections until 2044 in China. Cancers. 2022;14(16):3883. PubMed DOI PMC

Miao X, Yao T, Dong C, Chen Z, Wei W, Shi Z, et al. Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990–2019 and prediction to 2035: worsening or improving? BMC Public Health. 2024;24(1):832. PubMed DOI PMC

Girardi FA, Nogueira MC, Malta DC, Pissolati Simão FE, Bustamante-Teixeira MT, Guerra MR. The burden of lung cancer and mortality attributable to occupational risk factors between 1990 and 2019 in Brazil and federative units. Public Health. 2024;235:94–101. PubMed DOI

Dai X, Gakidou E, Lopez AD. Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. Tob Control. 2022;31(2):129–37. PubMed DOI

Zhong R, Cai X, Li J, Chen P, Wang R, Li X, et al. Asian, regional, and national burdens of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the global burden of disease study 2019. Chinese Medical Journal Pulmonary and Critical Care Medicine. 2023;1(4):249–58. PubMed DOI PMC

Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159–67. PubMed DOI PMC

Ren F, Liu G. Global, regional, and national burden and trends of air pollution-related neoplasms from 1990 to 2019: An observational trend study from the Global Burden of Disease Study 2019. Ecotoxicol Environ Saf. 2024;285: 117068. PubMed DOI

Torre LA, Siegel RL, Jemal A. Lung Cancer Statistics. In: Ahmad A, Gadgeel S, editors. Lung Cancer and Personalized Medicine. (Advances in Experimental Medicine and Biology; vol. 893). Cham: Springer International Publishing; 2016. pp. 1–19. Available from: http://link.springer.com/10.1007/978-3-319-24223-1_1. Cited 2024 Sep 4. PubMed DOI

Huang J, Chan SC, Pang WS, Chow SH, Lok V, Zhang L, et al. Global Incidence, Risk Factors, and Temporal Trends of Mesothelioma: A Population-Based Study. J Thorac Oncol. 2023;18(6):792–802. PubMed DOI

Li X, Su X, Wei L, Zhang J, Shi D, Wang Z. Assessing trends and burden of occupational exposure to asbestos in the United States: a comprehensive analysis from 1990 to 2019. BMC Public Health. 2024;24(1):1404. PubMed PMC

Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, et al. The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure. Occup Environ Med. 2018;75(4):254–62. PubMed DOI PMC

Jiang Z, Chen T, Chen J, Ying S, Gao Z, He X, et al. Hand-spinning chrysotile exposure and risk of malignant mesothelioma: A case-control study in Southeastern China: Asbestos exposure and malignant mesothelioma. Int J Cancer. 2018;142(3):514–23. PubMed DOI

Schumacher AE, Kyu HH, Aali A, Abbafati C, Abbas J, Abbasgholizadeh R, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):1989–2056. PubMed DOI PMC

Visonà SD, Capella S, Bodini S, Borrelli P, Villani S, Crespi E, et al. Inorganic Fiber Lung Burden in Subjects with Occupational and/or Anthropogenic Environmental Asbestos Exposure in Broni (Pavia, Northern Italy): An SEM-EDS Study on Autoptic Samples. IJERPH. 2021;18(4):2053. PubMed DOI PMC

Lipfert FW, Wyzga RE. Longitudinal relationships between lung cancer mortality rates, smoking, and ambient air quality: a comprehensive review and analysis. Crit Rev Toxicol. 2019;49(9):790–818. PubMed DOI

Kamp DW. Asbestos-induced lung diseases: an update. Transl Res. 2009;153(4):143–52. PubMed DOI PMC

Driscoll T, Nelson DI, Steenland K, Leigh J, Concha-Barrientos M, Fingerhut M, et al. The global burden of disease due to occupational carcinogens. American J Industrial Med. 2005;48(6):419–31. PubMed DOI

Kramer D, McMillan K, Gross E, Kone Pefoyo AJ, Bradley M, Holness DL. From Awareness to Action: The Community of Sarnia Mobilizes to Protect its Workers from Occupational Disease. New Solut. 2015;25(3):377–410. PubMed DOI

Marsili D, Canepa A, Mossone N, Comba P. Environmental health education for asbestos-contaminated communities in Italy: The Casale Monferrato case study. Annals of Global Health. 2019;85(1):84. PubMed PMC

Soeberg M, Vallance D, Keena V, Takahashi K, Leigh J. Australia’s Ongoing Legacy of Asbestos: Significant Challenges Remain Even after the Complete Banning of Asbestos Almost Fifteen Years Ago. IJERPH. 2018;15(2):384. PubMed DOI PMC

European Trade Union Institute (ETUI). Enormous gaps identified in the recognition of occupational cancers in Europe. ETUI. 2018; Available from: https://www.etui.org/topics/health-safety-working-conditions/news-list/enormous-gaps-identified-in-the-recognition-of-occupational-cancers-in-europe. Cited 2025 Jul 12.

Marine Cavet, Xabier Irastorza, Elke Schneider, Nadia Vilahur. Workers’ exposure survey on cancer risk factors (WES): Description and key findings. Luxembourg: European Agency for Safety and Health at Work (EU-OSHA); 2024. Available from: https://osha.europa.eu/en/publications/workers-exposure-survey-cancer-risk-factors-wes-description-and-key-findings. Cited 2025 Jul 12.